Page last updated: 2024-10-24

negative regulation of transcription initiation by RNA polymerase II

Definition

Target type: biologicalprocess

Any process that decreases the rate, frequency or extent of a process involved in starting transcription from an RNA polymerase II promoter. [GOC:dph, GOC:tb, GOC:txnOH]

Negative regulation of transcription initiation by RNA polymerase II is a complex process that involves a wide range of molecular mechanisms to control the expression of genes. This process is essential for maintaining cellular homeostasis and responding to various environmental cues. Here's a detailed description of the biological process:

**1. Transcriptional Repressors:**
- Specific proteins called transcriptional repressors bind to DNA sequences located near the promoter region of target genes. These sequences are often called repressor binding sites.
- Repressors can block the binding of RNA polymerase II to the promoter, preventing the initiation of transcription.

**2. Chromatin Remodeling:**
- The DNA in eukaryotic cells is packaged into chromatin, a complex of DNA and proteins. The structure of chromatin can influence the accessibility of DNA to transcription factors and RNA polymerase II.
- Repressors can recruit chromatin remodeling complexes that alter the structure of chromatin, making the DNA less accessible. This can hinder the binding of RNA polymerase II and other factors necessary for transcription initiation.

**3. Histone Modifications:**
- Histones are proteins that associate with DNA to form nucleosomes, the basic units of chromatin.
- Repressors can recruit enzymes that modify histones by adding or removing specific chemical groups, such as acetyl, methyl, or phosphate groups.
- These modifications can alter the affinity of histones for DNA, making the DNA more or less accessible to transcription factors and RNA polymerase II.

**4. Co-repressor Complexes:**
- Repressors often interact with co-repressor complexes, which are multi-protein complexes that enhance the repressive activity of the repressor.
- These complexes can mediate various repressive mechanisms, such as chromatin remodeling, histone modifications, and recruitment of other repressors.

**5. Competition with Activators:**
- Repressors can compete with activators for binding to the promoter region of genes. Activators are proteins that enhance transcription by facilitating the recruitment of RNA polymerase II and other factors.
- Repressors can outcompete activators, preventing them from binding to the promoter and activating transcription.

**6. Signaling Pathways:**
- Repressors can be regulated by signaling pathways that respond to various environmental cues, such as stress, hormones, and nutrient availability.
- These signaling pathways can activate or inhibit repressors, allowing for rapid and dynamic regulation of gene expression.

**7. RNA Interference (RNAi):**
- In some cases, RNA interference (RNAi) can play a role in negative regulation of transcription initiation.
- Small RNA molecules, such as microRNAs (miRNAs), can bind to target messenger RNA (mRNA) molecules, preventing their translation into proteins.
- In some instances, miRNAs can also interact with specific proteins involved in transcription initiation, ultimately inhibiting the process.

**In summary, negative regulation of transcription initiation by RNA polymerase II is a multi-faceted process that involves a diverse array of molecular mechanisms. This intricate system allows for precise control of gene expression, ensuring that genes are only transcribed when and where they are needed.**'
"

Proteins (2)

ProteinDefinitionTaxonomy
Myc proto-oncogene proteinA c-myc protein that is encoded in the genome of chicken. [OMA:P01109, PRO:DNx]Gallus gallus (chicken)
Myc proto-oncogene proteinA c-myc protein that is encoded in the genome of human. [PRO:CNA, UniProtKB:P01106]Homo sapiens (human)

Compounds (10)

CompoundDefinitionClassesRoles
aurintricarboxylic acidaurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'.

Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.
monohydroxybenzoic acid;
quinomethanes;
tricarboxylic acid
fluorochrome;
histological dye;
insulin-like growth factor receptor 1 antagonist
mefenamic acidmefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
aminobenzoic acid;
secondary amino compound
analgesic;
antipyretic;
antirheumatic drug;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
methyl redmethyl red : An azo dye consisting of benzoic acid substituted at position 2 by a 4-[(dimethylamino)phenyl]diazenyl group.

methyl red: RN given refers to parent cpd; structure
3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine1,2,4-triazines
avasimibemonoterpenoid
resveratroltrans-resveratrol : A resveratrol in which the double bond has E configuration.resveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
10074-g510074-G5: structure in first source
tws 119pyrroles
sgi-1027SGI-1027: inhibits DNA methyltransferase 1; structure in first source
kj-pyr-9KJ-Pyr-9: antineoplastic; structure in first source